Concepts (205)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Sepsis | 19 | 2020 | 139 | 2.490 |
Why?
|
| Inflammation | 17 | 2019 | 524 | 1.680 |
Why?
|
| Sirtuin 1 | 11 | 2020 | 32 | 1.460 |
Why?
|
| Lipopolysaccharides | 10 | 2019 | 100 | 1.340 |
Why?
|
| Transcription Factor RelB | 9 | 2013 | 21 | 1.270 |
Why?
|
| Lung Injury | 8 | 2018 | 64 | 1.210 |
Why?
|
| Immune Tolerance | 7 | 2018 | 64 | 1.180 |
Why?
|
| Contusions | 7 | 2018 | 41 | 0.950 |
Why?
|
| Endotoxins | 9 | 2016 | 32 | 0.910 |
Why?
|
| Energy Metabolism | 6 | 2019 | 139 | 0.900 |
Why?
|
| Leukocytes | 8 | 2017 | 50 | 0.900 |
Why?
|
| Epigenesis, Genetic | 5 | 2011 | 98 | 0.820 |
Why?
|
| Gene Silencing | 6 | 2009 | 47 | 0.730 |
Why?
|
| Promoter Regions, Genetic | 8 | 2011 | 224 | 0.710 |
Why?
|
| Sirtuins | 4 | 2018 | 18 | 0.640 |
Why?
|
| Monocytes | 5 | 2019 | 114 | 0.600 |
Why?
|
| Gene Expression Regulation | 9 | 2017 | 492 | 0.600 |
Why?
|
| Sirtuin 2 | 4 | 2019 | 10 | 0.590 |
Why?
|
| Heterochromatin | 3 | 2011 | 9 | 0.580 |
Why?
|
| Transcription, Genetic | 6 | 2011 | 141 | 0.570 |
Why?
|
| Lung | 5 | 2018 | 238 | 0.560 |
Why?
|
| Mice | 20 | 2020 | 2366 | 0.560 |
Why?
|
| Interleukin-1beta | 5 | 2011 | 43 | 0.550 |
Why?
|
| Histones | 7 | 2011 | 48 | 0.540 |
Why?
|
| NF-kappa B | 4 | 2013 | 74 | 0.530 |
Why?
|
| Toll-Like Receptor 4 | 6 | 2012 | 40 | 0.510 |
Why?
|
| Immunity, Innate | 5 | 2018 | 64 | 0.510 |
Why?
|
| Animals | 27 | 2020 | 7552 | 0.490 |
Why?
|
| Lung Diseases | 2 | 2009 | 48 | 0.470 |
Why?
|
| Tumor Necrosis Factor-alpha | 7 | 2016 | 203 | 0.460 |
Why?
|
| Interleukin-1 | 4 | 2006 | 33 | 0.460 |
Why?
|
| Neutrophil Infiltration | 1 | 2011 | 9 | 0.460 |
Why?
|
| Chromatin Assembly and Disassembly | 2 | 2009 | 5 | 0.410 |
Why?
|
| Mice, Inbred C57BL | 13 | 2020 | 704 | 0.390 |
Why?
|
| MicroRNAs | 1 | 2011 | 171 | 0.380 |
Why?
|
| Chemokine CXCL1 | 5 | 2012 | 16 | 0.370 |
Why?
|
| Transcription Factor RelA | 7 | 2019 | 21 | 0.360 |
Why?
|
| Systemic Inflammatory Response Syndrome | 1 | 2007 | 10 | 0.340 |
Why?
|
| Cysteine | 2 | 2019 | 127 | 0.340 |
Why?
|
| Disease Models, Animal | 11 | 2020 | 1040 | 0.330 |
Why?
|
| Humans | 28 | 2019 | 29292 | 0.300 |
Why?
|
| Glucose | 2 | 2017 | 168 | 0.270 |
Why?
|
| Cell Line | 9 | 2016 | 432 | 0.270 |
Why?
|
| Signal Transduction | 5 | 2018 | 743 | 0.250 |
Why?
|
| Homeostasis | 3 | 2018 | 149 | 0.250 |
Why?
|
| Intercellular Adhesion Molecule-1 | 5 | 2017 | 45 | 0.240 |
Why?
|
| Oxidative Stress | 3 | 2019 | 259 | 0.240 |
Why?
|
| I-kappa B Proteins | 3 | 2011 | 12 | 0.240 |
Why?
|
| Interleukin-6 | 4 | 2012 | 242 | 0.230 |
Why?
|
| Histocompatibility Antigens | 3 | 2009 | 8 | 0.220 |
Why?
|
| RNA, Messenger | 4 | 2016 | 544 | 0.220 |
Why?
|
| Histone-Lysine N-Methyltransferase | 3 | 2009 | 21 | 0.220 |
Why?
|
| Chemokine CXCL2 | 2 | 2011 | 9 | 0.220 |
Why?
|
| Drug Resistance | 2 | 2011 | 35 | 0.210 |
Why?
|
| Microvessels | 2 | 2017 | 26 | 0.210 |
Why?
|
| Cardiomyopathies | 1 | 2020 | 52 | 0.210 |
Why?
|
| Membrane Glycoproteins | 3 | 2014 | 99 | 0.210 |
Why?
|
| Adaptive Immunity | 1 | 2018 | 13 | 0.190 |
Why?
|
| Pyruvate Dehydrogenase Complex | 1 | 2018 | 13 | 0.190 |
Why?
|
| Stilbenes | 2 | 2015 | 27 | 0.190 |
Why?
|
| Protein Stability | 3 | 2013 | 27 | 0.190 |
Why?
|
| Shock, Septic | 1 | 2018 | 27 | 0.190 |
Why?
|
| Male | 14 | 2020 | 18658 | 0.180 |
Why?
|
| Platelet Adhesiveness | 3 | 2015 | 14 | 0.180 |
Why?
|
| Antioxidants | 1 | 2018 | 113 | 0.180 |
Why?
|
| Mice, Knockout | 4 | 2017 | 429 | 0.170 |
Why?
|
| Phenotype | 2 | 2014 | 666 | 0.170 |
Why?
|
| Vasculitis | 1 | 2017 | 24 | 0.170 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 2 | 2015 | 68 | 0.170 |
Why?
|
| Glyceraldehyde-3-Phosphate Dehydrogenase (Phosphorylating) | 1 | 2016 | 4 | 0.160 |
Why?
|
| RNA Processing, Post-Transcriptional | 1 | 2016 | 5 | 0.160 |
Why?
|
| Protein Binding | 3 | 2011 | 196 | 0.150 |
Why?
|
| Immunity, Cellular | 1 | 2015 | 20 | 0.150 |
Why?
|
| Bronchoalveolar Lavage Fluid | 4 | 2018 | 66 | 0.140 |
Why?
|
| Immunity | 1 | 2014 | 20 | 0.140 |
Why?
|
| Complement Activation | 1 | 2014 | 11 | 0.140 |
Why?
|
| Wounds, Nonpenetrating | 2 | 2014 | 95 | 0.140 |
Why?
|
| Obesity | 4 | 2019 | 1104 | 0.140 |
Why?
|
| Chemokines, CXC | 2 | 2011 | 9 | 0.140 |
Why?
|
| Protein Biosynthesis | 2 | 2011 | 49 | 0.140 |
Why?
|
| Toll-Like Receptor 2 | 3 | 2012 | 14 | 0.140 |
Why?
|
| Transcriptional Activation | 2 | 2005 | 48 | 0.140 |
Why?
|
| Receptors, Aryl Hydrocarbon | 1 | 2013 | 10 | 0.130 |
Why?
|
| Circadian Rhythm | 1 | 2013 | 45 | 0.130 |
Why?
|
| Mice, Obese | 3 | 2019 | 21 | 0.130 |
Why?
|
| Cytokines | 3 | 2012 | 243 | 0.130 |
Why?
|
| Cells, Cultured | 3 | 2018 | 793 | 0.130 |
Why?
|
| Phosphorylation | 2 | 2011 | 256 | 0.130 |
Why?
|
| Alzheimer Disease | 1 | 2016 | 281 | 0.120 |
Why?
|
| Immunohistochemistry | 2 | 2015 | 502 | 0.120 |
Why?
|
| Fatty Acids | 1 | 2012 | 89 | 0.120 |
Why?
|
| Receptors, Interleukin-8B | 1 | 2011 | 4 | 0.120 |
Why?
|
| Models, Immunological | 1 | 2011 | 10 | 0.110 |
Why?
|
| Cerebrovascular Circulation | 1 | 2011 | 90 | 0.110 |
Why?
|
| Adiponectin | 1 | 2011 | 121 | 0.110 |
Why?
|
| Curcumin | 1 | 2010 | 7 | 0.110 |
Why?
|
| Nucleosomes | 1 | 2009 | 2 | 0.100 |
Why?
|
| NF-kappa B p50 Subunit | 2 | 2008 | 4 | 0.100 |
Why?
|
| Peroxidase | 1 | 2009 | 27 | 0.100 |
Why?
|
| Myeloid Differentiation Factor 88 | 1 | 2009 | 16 | 0.100 |
Why?
|
| HMGB1 Protein | 1 | 2009 | 5 | 0.100 |
Why?
|
| NAD | 3 | 2016 | 21 | 0.100 |
Why?
|
| Cell Adhesion | 3 | 2017 | 105 | 0.100 |
Why?
|
| Models, Biological | 3 | 2009 | 373 | 0.100 |
Why?
|
| Chromosomal Proteins, Non-Histone | 1 | 2008 | 10 | 0.100 |
Why?
|
| Transfection | 2 | 2016 | 185 | 0.100 |
Why?
|
| Cardiovascular Diseases | 1 | 2016 | 1102 | 0.090 |
Why?
|
| Blotting, Western | 2 | 2020 | 281 | 0.090 |
Why?
|
| Repressor Proteins | 1 | 2006 | 55 | 0.080 |
Why?
|
| Inflammation Mediators | 1 | 2006 | 103 | 0.080 |
Why?
|
| Protein Precursors | 1 | 2005 | 18 | 0.080 |
Why?
|
| Binding Sites | 1 | 2005 | 122 | 0.080 |
Why?
|
| Oxidation-Reduction | 2 | 2019 | 235 | 0.070 |
Why?
|
| E-Selectin | 2 | 2017 | 21 | 0.070 |
Why?
|
| Glycolysis | 2 | 2016 | 22 | 0.070 |
Why?
|
| Cell Line, Tumor | 1 | 2006 | 715 | 0.070 |
Why?
|
| Adaptation, Biological | 1 | 2003 | 8 | 0.060 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2003 | 50 | 0.060 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2016 | 160 | 0.060 |
Why?
|
| Receptors, Cell Surface | 1 | 2003 | 68 | 0.060 |
Why?
|
| Dealkylation | 1 | 2002 | 2 | 0.060 |
Why?
|
| Blotting, Northern | 1 | 2002 | 28 | 0.060 |
Why?
|
| Half-Life | 1 | 2002 | 24 | 0.060 |
Why?
|
| Histone Deacetylase Inhibitors | 1 | 2002 | 18 | 0.060 |
Why?
|
| Genes, Reporter | 1 | 2002 | 36 | 0.060 |
Why?
|
| Chromatin | 1 | 2002 | 16 | 0.060 |
Why?
|
| Immunoblotting | 2 | 2015 | 56 | 0.060 |
Why?
|
| Microcirculation | 2 | 2011 | 59 | 0.060 |
Why?
|
| Enzyme Inhibitors | 1 | 2002 | 162 | 0.060 |
Why?
|
| Blood-Brain Barrier | 2 | 2011 | 45 | 0.060 |
Why?
|
| Echocardiography | 1 | 2020 | 160 | 0.050 |
Why?
|
| Myocytes, Cardiac | 1 | 2020 | 107 | 0.050 |
Why?
|
| Carbohydrate Metabolism | 1 | 2019 | 11 | 0.050 |
Why?
|
| Nucleotides | 1 | 2019 | 14 | 0.050 |
Why?
|
| Carnitine | 1 | 2019 | 8 | 0.050 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2019 | 48 | 0.050 |
Why?
|
| RNA Interference | 2 | 2009 | 69 | 0.050 |
Why?
|
| Principal Component Analysis | 1 | 2019 | 62 | 0.050 |
Why?
|
| Metabolome | 1 | 2019 | 29 | 0.050 |
Why?
|
| Amino Acids | 1 | 2019 | 40 | 0.050 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2018 | 58 | 0.050 |
Why?
|
| Lipid Metabolism | 1 | 2019 | 101 | 0.050 |
Why?
|
| Neutrophils | 2 | 2009 | 105 | 0.040 |
Why?
|
| DNA Mutational Analysis | 1 | 2017 | 74 | 0.040 |
Why?
|
| Adult | 1 | 2011 | 8719 | 0.040 |
Why?
|
| Aged | 1 | 2011 | 10068 | 0.040 |
Why?
|
| DNA Methylation | 2 | 2008 | 140 | 0.040 |
Why?
|
| Mitochondria | 1 | 2018 | 181 | 0.040 |
Why?
|
| Female | 2 | 2015 | 18970 | 0.040 |
Why?
|
| Immunoprecipitation | 1 | 2016 | 34 | 0.040 |
Why?
|
| Adenosine Triphosphate | 1 | 2016 | 48 | 0.040 |
Why?
|
| Gene Knockdown Techniques | 1 | 2016 | 75 | 0.040 |
Why?
|
| Middle Aged | 1 | 2011 | 11572 | 0.040 |
Why?
|
| RNA, Small Interfering | 1 | 2016 | 106 | 0.040 |
Why?
|
| Cecum | 1 | 2015 | 9 | 0.040 |
Why?
|
| Ribonucleotide Reductases | 1 | 2015 | 6 | 0.040 |
Why?
|
| Cell Adhesion Molecules | 1 | 2015 | 48 | 0.040 |
Why?
|
| Reactive Oxygen Species | 1 | 2016 | 162 | 0.040 |
Why?
|
| Polymerase Chain Reaction | 1 | 2015 | 176 | 0.040 |
Why?
|
| Macrophages | 1 | 2016 | 172 | 0.040 |
Why?
|
| Carbazoles | 1 | 2014 | 6 | 0.040 |
Why?
|
| Complement C5a | 1 | 2014 | 2 | 0.040 |
Why?
|
| Receptor, Anaphylatoxin C5a | 1 | 2014 | 2 | 0.040 |
Why?
|
| Intestine, Small | 1 | 2014 | 36 | 0.040 |
Why?
|
| Hirudins | 1 | 2014 | 23 | 0.030 |
Why?
|
| Thrombin | 1 | 2014 | 19 | 0.030 |
Why?
|
| Intestinal Mucosa | 1 | 2014 | 60 | 0.030 |
Why?
|
| Spleen | 1 | 2014 | 83 | 0.030 |
Why?
|
| Bone Marrow Cells | 1 | 2014 | 115 | 0.030 |
Why?
|
| Survival Rate | 1 | 2016 | 857 | 0.030 |
Why?
|
| Endothelial Cells | 1 | 2014 | 173 | 0.030 |
Why?
|
| Monocyte-Macrophage Precursor Cells | 1 | 2012 | 2 | 0.030 |
Why?
|
| Glucose Transporter Type 1 | 1 | 2012 | 7 | 0.030 |
Why?
|
| Nicotinamide Phosphoribosyltransferase | 1 | 2012 | 10 | 0.030 |
Why?
|
| Heat-Shock Proteins | 1 | 2012 | 27 | 0.030 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2012 | 23 | 0.030 |
Why?
|
| Adaptation, Physiological | 1 | 2012 | 54 | 0.030 |
Why?
|
| RNA-Binding Proteins | 1 | 2012 | 53 | 0.030 |
Why?
|
| Radioimmunodetection | 1 | 2011 | 3 | 0.030 |
Why?
|
| Rats | 2 | 2007 | 1750 | 0.030 |
Why?
|
| Fluorescence | 1 | 2011 | 19 | 0.030 |
Why?
|
| Bone Marrow Transplantation | 1 | 2012 | 79 | 0.030 |
Why?
|
| Microscopy | 1 | 2011 | 29 | 0.030 |
Why?
|
| Video Recording | 1 | 2011 | 50 | 0.030 |
Why?
|
| Carrier Proteins | 1 | 2012 | 117 | 0.030 |
Why?
|
| Leukocyte Rolling | 1 | 2010 | 2 | 0.030 |
Why?
|
| Transcription Factors | 1 | 2012 | 185 | 0.030 |
Why?
|
| Microscopy, Video | 1 | 2010 | 8 | 0.030 |
Why?
|
| P-Selectin | 1 | 2010 | 12 | 0.030 |
Why?
|
| Treatment Outcome | 1 | 2018 | 3173 | 0.030 |
Why?
|
| Response Elements | 1 | 2009 | 14 | 0.030 |
Why?
|
| Lysine | 1 | 2009 | 25 | 0.030 |
Why?
|
| Methylation | 1 | 2009 | 6 | 0.020 |
Why?
|
| Trauma Severity Indices | 1 | 2009 | 48 | 0.020 |
Why?
|
| T-Lymphocytes | 1 | 2009 | 117 | 0.020 |
Why?
|
| CpG Islands | 1 | 2008 | 47 | 0.020 |
Why?
|
| DNA | 1 | 2008 | 207 | 0.020 |
Why?
|
| Chemokines, CC | 1 | 2006 | 5 | 0.020 |
Why?
|
| Neutrophil Activation | 1 | 2006 | 5 | 0.020 |
Why?
|
| Genotype | 1 | 2007 | 839 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2006 | 813 | 0.020 |
Why?
|
| Teichoic Acids | 1 | 2003 | 7 | 0.020 |
Why?
|
| Interleukin-1 Receptor-Associated Kinases | 1 | 2003 | 15 | 0.020 |
Why?
|
| Toll-Like Receptors | 1 | 2003 | 23 | 0.020 |
Why?
|
| Protein Kinases | 1 | 2003 | 32 | 0.020 |
Why?
|